We are live on ! Find out more
CRIG

Charter Research & Investment Group Portfolio holdings

AUM $150M
1-Year Est. Return 28.05%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+28.05%
3 Year Est. Return
+71.14%
5 Year Est. Return
+100.32%
10 Year Est. Return
–
AUM
$98.4M
AUM Growth
+$6.04M
Cap. Flow
-$783K
Cap. Flow %
-0.8%
Top 10 Hldgs %
40.03%
Holding
80
New
5
Increased
28
Reduced
20
Closed
2

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$715K
2
HON icon
Honeywell
HON
+$241K
3
DUK icon
Duke Energy
DUK
+$213K
4
CSX icon
CSX Corp
CSX
+$204K
5
BDX icon
Becton Dickinson
BDX
+$194K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.27M
2
GE icon
GE Aerospace
GE
+$431K
3
NEU icon
NewMarket
NEU
+$363K
4
KHC icon
Kraft Heinz
KHC
+$310K
5
JNJ icon
Johnson & Johnson
JNJ
+$300K

Sector Composition

Rank Sector Weight
1 Communication Services 18.84%
2 Healthcare 15.16%
3 Consumer Staples 14.39%
4 Technology 14.17%
5 Financials 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSX icon
76
CSX Corp
CSX
$93.1B
$208K 0.21%
+8,640
New +$204K
BDX icon
77
Becton Dickinson
BDX
$48.2B
$207K 0.21%
+780
New +$194K
CELG.RT
78
Bristol-Myers Squibb Rights
CELG.RT
$224M
$39K 0.04%
+12,797
New +$5.57K
NEU icon
79
NewMarket
NEU
$8.18B
– –
-768
Closed -$363K
CELG
80
DELISTED
Celgene Corp
CELG
– –
-12,757
Closed -$1.27M
1 2 3
4

Similar funds

RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
JIM
JCP Investment Management Houston, Texas $150M AUM 19.22% 1-Year Est. Return
FC
FACT Capital New York $150M AUM 53.4% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
AIA
Accelerate Investment Advisors Aliso Viejo, California $150M AUM 17.82% 1-Year Est. Return
WBCM
Wilson & Boucher Capital Management Moraga, California $151M AUM 18.75% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $149M AUM

Charter Research & Investment Group's Q4 2019 Portfolio in Review

As of Q4 2019, Charter Research & Investment Group held 80 positions worth $98.4M, up 6.5% from $92.3M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Charter Research & Investment Group's Q4 2019 filing shows 5 new, 28 increased, 20 reduced and 2 closed positions. Its largest new stake was Honeywell: 1,473 shares worth $246K. The largest sale was Celgene Corp, an estimated $1.27M.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Charter Research & Investment Group's largest Q4 2019 buy was Honeywell: 1,473 shares worth $246K.
  • Charter Research & Investment Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $715K increase.
  • Charter Research & Investment Group's biggest Q4 2019 reduction was GE Aerospace, cutting an estimated $431K.
  • Charter Research & Investment Group fully exited Celgene Corp in Q4 2019, selling an estimated $1.27M.
  • Charter Research & Investment Group's ten largest holdings make up 40% of its $98.4M portfolio in Q4 2019.
  • Charter Research & Investment Group opened 5 new positions and closed 2 in Q4 2019.
  • Charter Research & Investment Group's portfolio value rose 6.5% quarter-over-quarter to $98.4M.

Based on Charter Research & Investment Group's 13F filing for Q4 2019, filed 30 Jan 2020.